A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome

Journal: Science Translational Medicine

Published: 2019-07-10

DOI: 10.1126/scitranslmed.aav5467

Affiliations: 29

Authors: 39

Go to article
Institutions Share
Institut Cochin, France 0.13
University of Paris, France 0.13
UCLA Department of Medicine, United States of America (USA) 0.08
Department of Development Reproduction and Cancer (DRC), Institut Cochin, France 0.07
Universitätsklinikum Leipzig, Germany 0.05
Digestive Health Research Institute (IRSD), France 0.05
Department of Genetics and Developmental Biology, France 0.05
Genetics and Biology of Cancers, France 0.05
Le Globule Rouge/The Red Cell (GR-Ex), France 0.04
Centre de Recherche sur l’Inflammation (CRI), France 0.03
Department of Translational Research, Curie Institute, France 0.03
Mediterranean Centre for Molecular Medicine (C3M), France 0.03
Genomics Platform, IGR, France 0.03
University Hospital Carl Gustav Carus Dresden, TU Dresden, Germany 0.03
Careggi University Hospital (AOUC), UNIFI, Italy 0.03
CHU Henri-Mondor, France 0.03
Centre Hospitalier Universitaire d'Angers (CHU d'Angers), France 0.03
Rouen University Hospital-Charles Nicolle (CHU de Rouen), France 0.03
Leukemic Niche and RedOx Metabolism (LNOx), France 0.03
Cochin Hospital, France 0.02
Grenoble Alpes University (UGA), France 0.01
Hôpital Saint-Louis, France 0.01
Bioinformatics Platform, Imagine Institute, France 0.01
Hôpital Necker-Enfants Malades, France 0.01
Alps Grenoble University Hospital (CHU Grenoble Alpes), France 0.01
Plate-Forme Protéomique Paris 5 (3P5), Université de Paris, France 0.01

Return